| 标题 |
 Efficacy and safety results from EMERALD-3: A phase 3, randomized study of tremelimumab plus durvalumab with or without lenvatinib combined with transarterial chemoembolization (TACE) in participants (pts) with unresectable embolization-eligible hepatocellular carcinoma (eeHCC) |
| 网址 | |
| DOI | |
| 其它 |
期刊：Journal of Clinical Oncology 作者：Ghassan K. Abou-Alfa; Zhenggang Ren; Joseph Patrick Erinjeri; Jeong Heo; Riccardo Lencioni; et al 出版日期：2026-06-10 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时，文件已从服务器自动删除，无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)
Kao
Copyright
cdercder
OK
sanvva
Oracle
yanyanmi
雪海
嘉心糖
大力的冬萱
愉快的真
Criminology34
lieaait
zhaiyiying
TSUKIMI
有点奔
sagitar
cx
学霸业
Albert_Z
皖公网安备34019202002308
